Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-18

Clinical Trial Update: Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating simvastatin with or without ezetimibe and assessing atherothrombotic biomarkers in metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2014-12-18